Leadless pacemaker implant in patients with pre-existing infections: Results from the Micra postapproval registry.

导出 OA

翻译打印收藏纠错

作者： Mikhael F,El-Chami ^[1] ; Jens Brock,Johansen ^[2] ; Amir,Zaidi ^[3] ; Svein,Faerestrand ^[4] ; Dwight,Reynolds ^[5] ; Javier,Garcia-Seara ^[6] ; Jacques,Mansourati ^[7] ; Jean-Luc,Pasquie ^[8] ; Hugh Thomas,McElderry ^[9] ; Paul R,Roberts ^[10] ; Kyoko,Soejima ^[11] ; Kurt,Stromberg ^[12] ; Jonathan P,Piccini ^[13]

作者单位： Division of Cardiology, Section of Electrophysiology, Emory University, Atlanta, Georgia. ^[1] Department of Cardiology, Odense University Hospital, Odense, Denmark. ^[2] Division of Cardiology, Central Manchester University Hospitals, NHS Foundation Trust, Manchester, United Kingdom. ^[3] Department of Heart Disease, Haukeland University Hospital. ^[4] Department of Clinical Science, University of Bergen, Bergen, Norway. ^[5] Division of Cardiology, University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, Spain. ^[6] Division of Cardiology, Service de cardiologie, CHU de Brest, Brest, France. ^[7] Division of Cardiology, University of Montpellier, CHRU Montpellier, PHYMEDEXP, CNRS, INSERM, Montpellier, France. ^[8] Division of Cardiology, University of Alabama at Birmingham, Birmingham, Alabama. ^[9] Division of Cardiology, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom. ^[10] Division of Cardiology, Kyorin University Hospital, Tokyo, Japan. ^[11] Medtronic, plc, Mounds View, Minnesota. ^[12] Division of Cardiology, Duke University Medical Center and Duke Clinical Research Institute, Durham, North Carolina. ^[13]

关键词 Micra cardiac implantable electronic device infection leadless pacemakers permanent pacing transcatheter pacemaker